Year |
Citation |
Score |
2023 |
Jian L, Zscherp R, Beutling U, Shen X, Xu S, Zhang X, Brönstrup M, Klahn P, Sun Q. Discovery of Aminoratjadone Derivatives as Potent Noncovalent CRM1 Inhibitors. Journal of Medicinal Chemistry. PMID 37595020 DOI: 10.1021/acs.jmedchem.3c00549 |
0.348 |
|
2022 |
Liu J, Chai L, Zhang X. Advances in the Biological Functions of Extracellular Vesicles and their Potential Use in Treating Oral Cancer. Cell Biochemistry and Biophysics. PMID 36441372 DOI: 10.1007/s12013-022-01120-1 |
0.327 |
|
2021 |
Li Y, Liu X, Zhang X, Pan W, Li N, Tang B. Immunogenic cell death inducers for enhanced cancer immunotherapy. Chemical Communications (Cambridge, England). PMID 34714302 DOI: 10.1039/d1cc04604g |
0.306 |
|
2021 |
Liu X, Li Y, Wang K, Chen Y, Shi M, Zhang X, Pan W, Li N, Tang B. GSH-Responsive Nanoprodrug to Inhibit Glycolysis and Alleviate Immunosuppression for Cancer Therapy. Nano Letters. PMID 34494442 DOI: 10.1021/acs.nanolett.1c03089 |
0.304 |
|
2021 |
Zhang X, Taoka R, Liu D, Matsuoka Y, Tohi Y, Kakehi Y, Sugimoto M. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells. International Journal of Molecular Sciences. 22. PMID 33921102 DOI: 10.3390/ijms22084102 |
0.307 |
|
2019 |
Shen X, Zhao L, Chen P, Gong Y, Liu D, Zhang X, Dai L, Sun Q, Lou J, Jin Z, Zhang B, Niu D, Chen C, Qi X, Jia D. A thiazole-derived oridonin analog exhibits antitumor activity by directly and allosterically inhibiting STAT3. The Journal of Biological Chemistry. PMID 31594861 DOI: 10.1074/Jbc.Ra119.009801 |
0.345 |
|
2019 |
Zhu D, Zhang X, Lin Y, Liang S, Song Z, Dong C. MT1JP inhibits tumorigenesis and enhances cisplatin sensitivity of breast cancer cells through competitively binding to miR-24-3p. American Journal of Translational Research. 11: 245-256. PMID 30787983 |
0.312 |
|
2018 |
Wu P, Meng X, Zheng H, Zeng Q, Chen T, Wang W, Zhang X, Su J. Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer. Molecules (Basel, Switzerland). 23. PMID 30309003 DOI: 10.3390/Molecules23102592 |
0.337 |
|
2017 |
Guo Z, Sevrioukova IF, Denisov IG, Zhang X, Chiu TL, Thomas DG, Hanse EA, Cuellar RAD, Grinkova YV, Langenfeld VW, Swedien DS, Stamschror JD, Alvarez J, Luna F, Galván A, et al. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chemical Biology. 24: 1314. PMID 29053951 DOI: 10.1016/J.Chembiol.2017.09.012 |
0.595 |
|
2017 |
Guo Z, Sevrioukova IF, Denisov IG, Zhang X, Chiu TL, Thomas DG, Hanse EA, Cuellar RAD, Grinkova YV, Langenfeld VW, Swedien DS, Stamschror JD, Alvarez J, Luna F, Galván A, et al. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chemical Biology. PMID 28919040 DOI: 10.1016/J.Chembiol.2017.08.009 |
0.6 |
|
2017 |
Zhang X, Zhang X, Li Y, Shao Y, Xiao J, Zhu G, Li F. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Cell Death & Disease. 8: e2820. PMID 28542136 DOI: 10.1038/cddis.2017.85 |
0.327 |
|
2016 |
Guo Z, Sevrioukova I, Hanse E, Zhang X, Denisov I, Chiu T, Cuellar R, Torres C, Wulfkuhle J, Petricoin E, Cao Q, Chu H, Norris B, Schumacher R, Kelekar A, et al. Abstract 44: Hexyl-benzyl-biguanide (HBB) potently and selectively inhibits CYP3A4 epoxygenase activity and inhibits EET stabilization of mitochondrial respiration in ER+HER2- breast cancer cells, inducing glycolysis and pyruvate biosynthesis Cancer Research. 76: 44-44. DOI: 10.1158/1538-7445.Am2016-44 |
0.435 |
|
2015 |
Guo Z, Sevrioukova IF, Hanse E, Denisov I, Zhang X, Chiu T, Swedien D, Stamschror J, Alvarez J, Ortiz WM, Morgan M, Maher M, Chavez KJ, Thomas D, Bae YK, et al. Abstract 3568: CYP3A4 epoxygenase activity mediates ER+ mammary tumor growth and angiogenesis, in part, through EET biosynthesis and is inhibited by biguanides Cancer Research. 75: 3568-3568. DOI: 10.1158/1538-7445.Am2015-3568 |
0.308 |
|
2014 |
Guo Z, Chavez KJ, Alvarez J, Zhang X, Norris B, Maher M, Morgan M, Schumacher RJ, Cuellar R, Sevrioukova IF, Poulos TL, Denisov I, Sligar SG, Gupta K, Blair IA, et al. Abstract 2689: Breast cancer inhibition by a novel and potent biguanide, N1-hexyl-N5-benzyl-biguanide Cancer Research. 74: 2689-2689. DOI: 10.1158/1538-7445.Am2014-2689 |
0.4 |
|
2013 |
Zhang J, Zhang H, Zhang X, Yu Z. Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells. Cytotechnology. 65: 457-65. PMID 23070539 DOI: 10.1007/s10616-012-9500-z |
0.308 |
|
2011 |
Zhang X, Diaz, Yee D. P4-01-14: Fulvestrant Regulates Epidermal Growth Factor (EGF) Ligands and Induces EGF Receptor Activation in MCF-7 Breast Cancer Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-01-14 |
0.323 |
|
2010 |
Zhang X, Wang X, Song X, Liu C, Shi Y, Wang Y, Afonja O, Ma C, Chen YH, Zhang L. Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo. Cancer Science. 101: 2163-70. PMID 20735432 DOI: 10.1111/J.1349-7006.2010.01664.X |
0.319 |
|
2009 |
Chiu TL, Solberg J, Patil S, Geders TW, Zhang X, Rangarajan S, Francis R, Finzel BC, Walters MA, Hook DJ, Amin EA. Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening. Journal of Chemical Information and Modeling. 49: 2726-34. PMID 19928768 DOI: 10.1021/Ci900186W |
0.328 |
|
2009 |
Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ, Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, Fu QZ, Chen YH, Zhang LN. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Science. 100: 1408-13. PMID 19493270 DOI: 10.1111/J.1349-7006.2009.01210.X |
0.368 |
|
2009 |
Zhang X, Bi C, Fan Y, Cui Q, Chen D, Xiao Y, Dou QP. Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity. International Journal of Molecular Medicine. 22: 677-82. PMID 18949390 |
0.324 |
|
2009 |
Zhang X, Seidel B, LaPara K, Yee D. MCF-7 cells selected for acquired resistance to an anti IGF-IR antibody remain sensitive to fulvestrant and to an IGFIR tyrosine kinase inhibitor (TKI). Cancer Research. 69: 72. DOI: 10.1158/0008-5472.Sabcs-72 |
0.35 |
|
2009 |
Zhang X, Yee D. Potential Benefit of an Agonistic Anti IGFIR Antibody (scFv-Fc) as an Effective Breast Cancer Therapy. Cancer Research. 69: 3125-3125. DOI: 10.1158/0008-5472.Sabcs-09-3125 |
0.364 |
|
2008 |
Xiao Y, Bi C, Fan Y, Cui C, Zhang X, Dou QP. L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells. International Journal of Oncology. 33: 1073-9. PMID 18949371 |
0.316 |
|
Show low-probability matches. |